E12 - Synthesizing Our Genetic Future, with Andrew Hessel

In this episode, we sit down with Andrew Hessel to discuss the future of synthetic biology. Andrew Hessel is the CEO of Humane Genomics Inc., a seed-stage company developing virus-based therapies for cancer, starting with dogs. He is a co-founder of the Genome Project-write, the international scientific effort working to engineer large genomes, including the human genome. From 2012-2017 Andrew was the Distinguished Researcher at Autodesk Life Sciences. He has been Singularity University faculty since 2009. His goal is to help people better understand and use living systems to meet the needs of society. To support the podcast, consider donating at: http://patreon.com/catcoherence